Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,600 | 25 | 56.7% |
| Travel and Lodging | $13,052 | 18 | 25.9% |
| Food and Beverage | $7,119 | 177 | 14.1% |
| Consulting Fee | $1,650 | 3 | 3.3% |
| Debt forgiveness | $12.67 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $18,258 | 88 | $0 (2024) |
| Lilly USA, LLC | $14,699 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $13,638 | 42 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $1,888 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $353.52 | 14 | $0 (2024) |
| GENZYME CORPORATION | $228.29 | 9 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $193.63 | 5 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $171.01 | 4 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $139.70 | 3 | $0 (2023) |
| Celgene Corporation | $138.28 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,395 | 122 | Lilly USA, LLC ($14,699) |
| 2023 | $10,647 | 67 | ABBVIE INC. ($9,921) |
| 2022 | $1,104 | 32 | ABBVIE INC. ($725.29) |
| 2021 | $287.44 | 3 | Celgene Corporation ($125.00) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.30 | General |
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: Immunology | ||||||
| 12/18/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.61 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $0.81 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Lilly USA, LLC | OMVOH (Drug) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: Immunology | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $0.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: IMMUNOLOGY | ||||||
| 11/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: VIROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: Immunology | ||||||
| 11/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.75 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 99 | 13,873 | $550,280 | $238,383 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 36 | 13,800 | $532,800 | $234,819 | 44.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 35 | 45 | $10,305 | $1,764 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $3,965 | $1,001 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 15 | $3,210 | $798.70 | 24.9% |
About Jenna Kopp
Jenna Kopp is a Primary Care healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2022. The National Provider Identifier (NPI) number assigned to this provider is 1851023345.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jenna Kopp has received a total of $50,433 in payments from pharmaceutical and medical device companies, with $38,395 received in 2024. These payments were reported across 224 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($28,600).
As a Medicare-enrolled provider, Kopp has provided services to 99 Medicare beneficiaries, totaling 13,873 services with total Medicare billing of $238,383. Data is available for 1 year (2023–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Primary Care
- Location Omaha, NE
- Active Since 06/24/2022
- Last Updated 06/24/2022
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1851023345
Products in Payments
- OMVOH (Drug) $11,537
- SKYRIZI (Biological) $11,419
- TREMFYA (Drug) $9,663
- RINVOQ (Biological) $6,485
- STELARA (Biological) $4,040
- ZENPEP (Drug) $1,695
- ENTYVIO (Biological) $329.98
- DUPIXENT (Biological) $300.12
- ZEPOSIA (Drug) $261.03
- CREON (Drug) $195.10
- VOWST (Biological) $192.81
- OCALIVA (Drug) $171.01
- REBYOTA (Biological) $139.70
- MAVYRET (Drug) $78.33
- VELSIPITY (Drug) $70.76
- IBSRELA (Drug) $69.02
- XIFAXAN (Drug) $41.91
- XELJANZ (Drug) $39.69
- DIFICID (Drug) $37.60
- SUCRAID (Drug) $35.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Omaha
Rabia Moukrad, Aprn, APRN
Primary Care — Payments: $5,846
Megan Lihs
Primary Care — Payments: $2,006
Keri Dillon, Aprn, Fnp-C, APRN, FNP-C
Primary Care — Payments: $1,967
Joseph Anthone, Aprn, APRN
Primary Care — Payments: $1,967
Julie Hutton
Primary Care — Payments: $1,539
Johnna Feik, Np, NP
Primary Care — Payments: $660.76